GSA Capital Partners LLP Reduces Stock Position in Encompass Health Co. (NYSE:EHC)

GSA Capital Partners LLP cut its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 61.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,525 shares of the company's stock after selling 5,703 shares during the quarter. GSA Capital Partners LLP's holdings in Encompass Health were worth $341,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in EHC. Harbor Capital Advisors Inc. boosted its position in shares of Encompass Health by 275.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company's stock worth $3,071,000 after acquiring an additional 26,270 shares in the last quarter. QRG Capital Management Inc. increased its stake in Encompass Health by 85.6% in the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company's stock valued at $1,232,000 after purchasing an additional 6,627 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Encompass Health during the second quarter worth approximately $2,204,000. Los Angeles Capital Management LLC lifted its position in shares of Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company's stock worth $4,860,000 after buying an additional 42,338 shares during the last quarter. Finally, Kennedy Capital Management LLC boosted its holdings in shares of Encompass Health by 19.6% in the 1st quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company's stock valued at $8,235,000 after buying an additional 16,318 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

Shares of Encompass Health stock traded up $1.72 during trading hours on Friday, hitting $101.12. 776,089 shares of the company were exchanged, compared to its average volume of 828,364. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a 50-day moving average of $97.11 and a 200-day moving average of $90.84. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The stock has a market capitalization of $10.19 billion, a price-to-earnings ratio of 24.43, a P/E/G ratio of 1.32 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.86 EPS. As a group, analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is 16.43%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Stephens reissued an "overweight" rating and issued a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. Truist Financial reissued a "buy" rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada raised their price target on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Wednesday, September 25th. Finally, Barclays increased their price objective on Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health has an average rating of "Buy" and a consensus price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.